# Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

> **NCT03568448** · — · ACTIVE_NOT_RECRUITING · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 30 (estimated)

## Conditions studied

- HER2 Negative Breast Cancer

## Interventions

- **OTHER:** Response monitoring (no intervention)

## Key facts

- **NCT ID:** NCT03568448
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-04-16
- **Primary completion:** 2020-01-22
- **Final completion:** 2027-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03568448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03568448, "Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT03568448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*